These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 37734417)

  • 1. Artificial intelligence for telemedicine diabetic retinopathy screening: a review.
    Nakayama LF; Zago Ribeiro L; Novaes F; Miyawaki IA; Miyawaki AE; de Oliveira JAE; Oliveira T; Malerbi FK; Regatieri CVS; Celi LA; Silva PS
    Ann Med; 2023; 55(2):2258149. PubMed ID: 37734417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial Intelligence in Community-Based Diabetic Retinopathy Telemedicine Screening in Urban China: Cost-effectiveness and Cost-Utility Analyses With Real-world Data.
    Lin S; Ma Y; Xu Y; Lu L; He J; Zhu J; Peng Y; Yu T; Congdon N; Zou H
    JMIR Public Health Surveill; 2023 Feb; 9():e41624. PubMed ID: 36821353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is Artificial Intelligence the Cost-Saving Lens to Diabetic Retinopathy Screening in Low- and Middle-Income Countries?
    Rizvi A; Rizvi F; Lalakia P; Hyman L; Frasso R; Sztandera L; Das AV
    Cureus; 2023 Sep; 15(9):e45539. PubMed ID: 37868419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Artificial Intelligence Algorithms for Diabetic Retinopathy Detection: Protocol for a Systematic Review and Meta-Analysis.
    Sesgundo Iii JA; Maeng DC; Tukay JA; Ascano MP; Suba-Cohen J; Sampang V
    JMIR Res Protoc; 2024 May; 13():e57292. PubMed ID: 38801771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Diabetic retinopathy screening guidelines in South-East Asia region using the context, challenges, and future technology.
    Takkar B; Das T; Thamarangsi T; Rani PK; Thapa R; Nayar PD; Rajalakshmi R; Choudhury N; Hanutsaha P
    Semin Ophthalmol; 2022 Jan; 37(1):97-104. PubMed ID: 34003720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Artificial intelligence for teleophthalmology-based diabetic retinopathy screening in a national programme: an economic analysis modelling study.
    Xie Y; Nguyen QD; Hamzah H; Lim G; Bellemo V; Gunasekeran DV; Yip MYT; Qi Lee X; Hsu W; Li Lee M; Tan CS; Tym Wong H; Lamoureux EL; Tan GSW; Wong TY; Finkelstein EA; Ting DSW
    Lancet Digit Health; 2020 May; 2(5):e240-e249. PubMed ID: 33328056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Digital innovations for retinal care in diabetic retinopathy.
    Vujosevic S; Limoli C; Luzi L; Nucci P
    Acta Diabetol; 2022 Dec; 59(12):1521-1530. PubMed ID: 35962258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Telemedicine, In-Home Testing and Artificial Intelligence to Alleviate an Increasingly Burdened Healthcare System: Diabetic Retinopathy.
    Pieczynski J; Kuklo P; Grzybowski A
    Ophthalmol Ther; 2021 Sep; 10(3):445-464. PubMed ID: 34156632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Health Economic and Safety Considerations for Artificial Intelligence Applications in Diabetic Retinopathy Screening.
    Xie Y; Gunasekeran DV; Balaskas K; Keane PA; Sim DA; Bachmann LM; Macrae C; Ting DSW
    Transl Vis Sci Technol; 2020 Apr; 9(2):22. PubMed ID: 32818083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial Intelligence Algorithms in Diabetic Retinopathy Screening.
    Zafar S; Mahjoub H; Mehta N; Domalpally A; Channa R
    Curr Diab Rep; 2022 Jun; 22(6):267-274. PubMed ID: 35438458
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of diabetic retinopathy screening programs using telemedicine: a systematic review.
    Avidor D; Loewenstein A; Waisbourd M; Nutman A
    Cost Eff Resour Alloc; 2020; 18():16. PubMed ID: 32280309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic Retinopathy Telemedicine Outcomes With Artificial Intelligence-Based Image Analysis, Reflex Dilation, and Image Overread.
    Mehra AA; Softing A; Guner MK; Hodge DO; Barkmeier AJ
    Am J Ophthalmol; 2022 Dec; 244():125-132. PubMed ID: 35970206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic accuracy of smartphone-based artificial intelligence systems for detecting diabetic retinopathy: A systematic review and meta-analysis.
    Hasan SU; Siddiqui MAR
    Diabetes Res Clin Pract; 2023 Nov; 205():110943. PubMed ID: 37805002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fairness and generalisability in deep learning of retinopathy of prematurity screening algorithms: a literature review.
    Nakayama LF; Mitchell WG; Ribeiro LZ; Dychiao RG; Phanphruk W; Celi LA; Kalua K; Santiago APD; Regatieri CVS; Moraes NSB
    BMJ Open Ophthalmol; 2023 Aug; 8(1):. PubMed ID: 37558406
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of artificial intelligence screening for diabetic retinopathy in rural China.
    Huang XM; Yang BF; Zheng WL; Liu Q; Xiao F; Ouyang PW; Li MJ; Li XY; Meng J; Zhang TT; Cui YH; Pan HW
    BMC Health Serv Res; 2022 Feb; 22(1):260. PubMed ID: 35216586
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Artificial intelligence for diabetic retinopathy screening: a review.
    Grzybowski A; Brona P; Lim G; Ruamviboonsuk P; Tan GSW; Abramoff M; Ting DSW
    Eye (Lond); 2020 Mar; 34(3):451-460. PubMed ID: 31488886
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An overview of artificial intelligence in diabetic retinopathy and other ocular diseases.
    Sheng B; Chen X; Li T; Ma T; Yang Y; Bi L; Zhang X
    Front Public Health; 2022; 10():971943. PubMed ID: 36388304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Satisfaction of patients and primary care professionals with a teleophthalmology-based screening programme for diabetic retinopathy in a rural area in Castilla y León, Spain.
    Valpuesta Martin Y; Pacheco Callirgos GE; Maroto Martín TM; Piriz Veloso M; Hernández Santamaría S; López Gálvez MI
    Rural Remote Health; 2020 Jan; 20(1):5180. PubMed ID: 31941342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis.
    Liu H; Li R; Zhang Y; Zhang K; Yusufu M; Liu Y; Mou D; Chen X; Tian J; Li H; Fan S; Tang J; Wang N
    Lancet Glob Health; 2023 Mar; 11(3):e456-e465. PubMed ID: 36702141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress in examining cost-effectiveness of AI in diabetic retinopathy screening.
    Dismuke C
    Lancet Digit Health; 2020 May; 2(5):e212-e213. PubMed ID: 33328051
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.